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ABSTRACT
Grouping Algorithms for Informative Array Testing in Disease Surveillance
David Sokolov
In order to maintain normal operations and prevent unnecessary morbidity and mortality during times of
disease outbreak, institutions find a need to conduct frequent and widespread testing of their constituents,
often under significantly limited testing resource constraints. Faced with the challenge of how best to allocate these limited resources to maximum effect, institutions are increasingly turning to group (or “pooled”)
testing, which involves testing strategically-chosen groups of patient samples rather than individual samples,
producing significant testing resource savings under certain regimes of disease prevalence. While group testing can be conducted without any a priori knowledge of individual disease risk probabilities, incorporating
such knowledge—a process called informative group testing—to assign testing groups has the potential to
further enhance testing efficiency. Here, we focus on one particular informative group testing procedure
which groups samples into two-dimensional arrays for disease status identification (so-called informative array testing). While others have reported algorithms to optimize the construction of a testing array given its
constituent samples, we focus instead on algorithms to assign array groups from a population with heterogenous disease risks. We propose two new array assignment strategies—concentrated risk and dispersed risk
array assignment—and compare their performance to random array assignment by simulating informative
array testing on a heterogenous-risk population. Overall, our results suggest that informative array testing
is surprisingly agnostic to array assignment strategy, with one potential exception at high disease prevalence.
Furthermore, our consideration of two distinct performance metrics reveals nuance in choosing an optimal
informative array testing strategy with regards to both test savings and case identification efficiency.
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1

Infectious Disease Surveillance as a Resource Allocation
Problem

1.1

Introduction

Communicable disease is a ubiquitous and ever-evolving feature of the human species. While organized
societies have long realized a need to effectively monitor and control infectious disease, today’s globalized
world is one in which disease outbreaks have the potential to spread extremely rapidly and cause significant
global disruptions if left unchecked. Our technological capabilities to detect, diagnose, and treat disease
have never been stronger—still, the ongoing COVID-19 pandemic has revealed the inherent difficulties of
managing a novel pathogen which emerges unexpectedly and spreads throughout the globe in a matter of
months [9].
As COVID-19 vaccines become more universal and population susceptibility correspondingly decreases,
institutions on all levels—governments, businesses, schools, and other administrative entities—realize a need
for effective disease surveillance in order to maintain normal operations and prevent unnecessary morbidity
and mortality. Current views in the field agree that effective disease mitigation and containment depends
on frequent and massive testing of susceptible populations [18], with one study even estimating that colleges should screen the entire student population every 2 days in order to prevent further outbreaks [15].
Considering that the COVID-19 pandemic disrupted global supply chains across the board [20] including
those necessary to manufacture testing reagents [1], the question of disease surveillance quickly becomes a
question of resource allocation—how can institutions, who need to control disease outbreaks among their
constituents, make best use of necessarily limited testing resources?
With specific regards to disease surveillance, group testing—also known as pooled testing—has emerged
as a viable method to conserve resources by extending the predictive power of a single diagnostic test. First
reported by Dorfman in 1943 as a means of screening army recruits for syphilis [5], group testing takes
advantage of many diagnostic tests’ abilities to be multiplexed; that is, for one test to be used on a mixture
of multiple patient samples. In a typical group testing setup, multiple patient samples will be combined
and tested with a single diagnostic test. If the test returns a negative result, the entire group is presumed
negative, while a positive test result necessitates the need for further testing on that group (sometimes known
as “retesting” or “decoding”) to definitively identify the patients responsible for the positive result [4]. Group
testing has the potential to significantly reduce testing resource expenditure under certain conditions; indeed,
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a group of size n which tests negative effectively saves n − 1 tests (which would otherwise be used to test
each patient individually). Intuitively, the relative test savings of group testing increases with decreasing
disease prevalence in the population [4]. By making better use of fewer testing resources and shortening the
time required to screen large populations for disease, group testing is increasingly recognized as effective and
necessary to control present outbreaks and prevent future ones [3].

1.2

Uninformative (“Naı̈ve”) Group Testing

Unsurprisingly, diverse algorithms exist for both major stages of the group testing approach (initial group
formation/testing and subsequent decoding of positive groups). While these algorithms vary in their relative
test-saving efficiencies, robustness to disease and test parameters, and implementation complexity, they can
be broadly classified into two groups: those which are agnostic to heterogeneity in individual disease risk
(uninformative or “naı̈ve” group testing algorithms) and those which consider patient-to-patient variation
in disease risk to further optimize test savings (informative group testing algorithms). While uninformative
group testing approaches may consider population-level estimates of disease prevalence to optimize group
sizes and can offer significant savings over individual testing [7], they ultimately treat each patient sample
as identical with regards to group assignment and subsequent decoding. What follows is a brief discussion
of several common uninformative group testing approaches.
The most straightforward uninformative group testing approach is known as Dorfman testing after its
original proposer. In this scheme, the testing population is randomly assigned to groups of equal size, each
of which are tested using a single test—groups which test positive are subsequently decoded using individual
testing [5]. One step further than this are the so-called “hierarchical” group testing schemes (sometimes
known as “multistage” or “splitting” algorithms). In these approaches, initial group assignment is similar to
Dorfman testing, but positive groups are split into smaller groups, which are again tested. Positive groups
can either be split in half (“binary splitting”), or into multiple smaller pools of different sizes, optimized
according to disease prevalence. This sequential group splitting can be repeated as many times as desired, but
in practice algorithms with more than four splitting stages are disfavored as the testing is too time-consuming
[4].
All of the aforementioned tests are sometimes classified under the umbrella term “adaptive” or “sequential” testing schemes—once initial groups are formed, they are sequentially retested and refined to decode
positive individuals. The adaptiveness of these approaches stems from the ability to optimize group size at
each step based on disease prevalence and the results of previous testing stages, and multiple such algorithms
2

have been developed over the past several years [4]. In contrast, so-called “non-adaptive” testing schemes
take a different approach—each individual sample is first assigned to multiple distinct groups, all groups
are tested, and combinatorial approaches are used to decode positive individuals after this single round (or
sometimes one additional round) of testing.
One of the most popular non-adaptive group testing approaches is matrix, or array, testing [13]. The
premise of this approach is to form individual samples in a two-dimensional array, then group test each row
and column of that array. Samples occurring at the intersection of a positive row and column are retested to
decode their disease status, yielding complete knowledge of a population’s disease status after only two rounds
of testing. With small modifications to account for imperfect tests, various array testing methodologies have
been shown to regularly outperform Dorfman testing and see application in many workflows for population
disease surveillance [4, 11, 16]. A major benefit of the array testing approach is the reduced testing time
associated with fewer testing rounds—in situations where adequate disease surveillance and contact tracing
depends on rapid case identification, non-adaptive approaches like array testing allow institutions to be more
responsive to changing infection landscapes than if they had relied on slower, multistage sequential testing
approaches [11].
Beyond array testing, more complex non-adaptive group testing algorithms exist which rely on strategic
sample distribution among multiple pools and subsequent case identification using sophisticated decoding
algorithms. While these approaches are beyond the scope of this investigation, they promise further efficiency
improvements over array testing, and many are currently undergoing clinical validation [4]. One potential
downside of these approaches is their relative complexity—some worry that real-world implementation of
these strategies (which require complicated sample pooling and dedicated decoding algorithms) in testing
laboratories carry increased risks of human error and case misidentification.

1.3

Informative Group Testing

In contrast to uninformative approaches, informative group testing algorithms take a major step forward
in considering individual disease risk heterogeneity when optimizing testing groups. Collectively, these approaches seek to leverage available data—clinical, epidemiological, or otherwise—to predict each individual’s
probability of testing positive, and use these predictions to construct groups in such a way as to maximize
test savings. While informative testing strategies depend on the availability and reliability of patient risk
data, they demonstrate significant performance improvements over their uninformative counterparts with
oftentimes negligible losses in screening accuracy [13, 12]. Of particular importance to containing disease
3

epidemics, informative group testing strategies show greater robustness to disease prevalence than uninformative methods—by strategically separating high- and low-risk patient samples, informative testing methods
often remain effective at higher disease prevalence, where traditional group testing methods falter [6].

1.4
1.4.1

Common Informative Group Testing Techniques
Informative Dorfman and Hierarchical Testing

From a big-picture perspective, informative Dorfman and hierarchical schemes seek to minimize test usage
by maximizing the occurrence of negative-testing groups. Two specific strategies described by McMahan and
colleagues are the so-called Threshold Optimal Dorfman (TOD) and Pool-Specific Optimal Dorfman (PSOD)
algorithms, which both seek to minimize the expected number of tests utilizing greedy algorithms and realistic
constraints [12]. The TOD algorithm works by individually testing all samples above an optimal upper risk
threshold and partitioning all lower-risk samples into equally sized groups of optimal size n determined
empirically. The PSOD approach rejects the idea of a common group size in favor of optimally-computed
groups of various sizes, dictated by the disease risk landscape of the population in question. Heuristically, one
can understand this algorithm as favoring larger groups of low-risk individuals and concentrating high-risk
individuals into fewer, smaller groups.
An alternative to the two algorithms above was recently proposed by Malinovsky and colleagues [10].
Their approach begins by partitioning a population into variable-sized groups and testing those groups.
Positive groups are further subdivided and tested—if, for instance, group A is split into subgroups A1 and
A2 and A1 returns a negative test, A2 is then inferred to contain the positive case, and is further subdivided
and tested. This process is repeated until all samples are decoded, and an optimal testing configuration
(OTC) (i.e. an optimal collection of groupings) is obtained by a backwards induction process which first
finds the OTC for two samples, then three, etc. While the principals behind this approach and PSOD are
similar, this algorithm claims several useful advantages over PSOD (for more details, see [10]), including a
faster computation time.

1.4.2

Informative Array Testing

As is usually the case for informative group testing procedures, informative array testing represents a slight
modification of traditional (uninformative) array testing to account for the extra knowledge of individual
patient disease risks. Unlike hierarchical testing approaches, an informative array approach presents two
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distinct steps at which to incorporate individual disease risk probabilities: partitioning of populations into
array groups, and construction of individual arrays from these groups.
Towards the latter step, two specific square array designs have been proposed; namely, “gradient” and
“spiral” array construction algorithms [13]. Both of these seek to minimize the number of positive array
rows and columns by grouping high-risk samples in close proximity to each other. Gradient construction
accomplishes this by placing the highest-risk sample in the first slot of the array, and sequentially filling
columns downward in order of decreasing risk (Figure 1). Meanwhile, spiral construction starts identically
to gradient, but then constructs concentric rings ordered by decreasing risk (Figure 1). Simulation studies
confirm that both spiral and gradient constructions outperformed random array constructions across a range
of disease prevalence, with gradient performing slightly more efficiently than spiral design [13]. Furthermore,
at prevelances below 10%, gradient array testing also outperformed the PSOD algorithm, though it was
not as efficient as Sterrett testing, a hierarchical testing strategy which has fallen out of favor due to its
potentially large amounts of sequential testing stages [2].

Figure 1: Schematic depicting two optimal array construction strategies (Gradient and Spiral Construction)
given individual disease risk probabilities. Circles represent individuals, colored according to disease risk.
Grey arrows illustrate the array filling order by descending risk.
One other recent study describes an improved approach to informative array testing, slightly generalizing
the concept of array testing to construct a series of groups, any two of which have only a single sample in
common [19]. While these authors show efficiency gains using their algorithm, their approach raises potential
concerns about ease of implementation and falls beyond the scope of this project.

5

1.5

Project Aims and Scope

The aim of the current project follows naturally from a surprising lack of results concerning the first step
of informative array testing described above—namely, how best to partition a population into array groups
according to individual disease risk probabilities. Stated differently, once a group of samples with known risks
is collected, multiple algorithms exist to strategically construct an array with a minimum expected number of
positive rows and columns; however, given a population with known risks, the method of assigning individual
samples to arrays in the first place has—to our knowledge—not been studied, and was hypothesized to affect
the overall efficiency of the array testing algorithm.
We hypothesized that this partitioning of population into array groups is not trivial, and would in fact
differ from similar grouping algorithms employed in hierarchical methods such as PSOD. This hypothesis
stemmed from the supposition that testing arrays tend to perform better with fewer positives in them (for
example, a single positive sample in an array can be pinpointed after only one round of testing, assuming
perfect tests), while hierarchical grouping optimization often seeks to concentrate positive samples to relatively few groups [4]. Along these lines, we also must consider that crude test savings are not the only
useful performance metric to evaluate group testing algorithms—for instance, the percentage of the population which are completely decoded after one round of testing is relevant to institutions conducting frequent
disease surveillance, and differ drastically between optimal array and non-array testing strategies [11].
Thus, this project aims to investigate informative array testing—specifically, the methods by which a population is partitioned into array groups using disease risk probabilities. We propose two new array grouping
algorithms and compare their performance to random array assignment. In addition, we compare our array
grouping algorithms to individual testing on a simulated population across a range of disease prevalence.
Overall, this project comprises an initial foray into further optimizing informative array testing for disease,
and serves as a foundation for further research improving upon model parameters and—eventually—clinical
investigations to investigate the effectiveness of informative array testing in practice.
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2

Investigating Grouping Algorithms for Informative Array
Testing

2.1

Introduction

To investigate optimal methods of partitioning a population into array groups for informative array testing,
we use random assignment as a baseline (and the apparent current standard in the field). In search of more
efficient array assignment algorithms, we consider two conceptual strategies: the first aims to maximize
the number of negative arrays (that is, arrays with no positive individuals) by concentrating the highestrisk individuals in relatively few arrays, while the second aims to maximize the number of arrays with few
positives by systematically dispersing the highest-risk individuals among the arrays. Accordingly, we refer to
these two strategies as “concentrated risk” and “dispersed risk” algorithms. Once array groups are assigned,
arrays are constructed using the gradient and spiral designs noted previously [13].

2.2

Population Construction and Disease Risk Assignment

A necessary first step in evaluating the performance of our group testing strategies is the simulation of
a population and corresponding disease risk probabilities. To this end, we create a population of 5,000
individuals (representing, perhaps, a medium-sized U.S. college seeking to screen a portion of its student
body on a given day). Each individual disease risk probability p is then randomly drawn from a beta
distribution with a specified mean risk value and standard deviation, as is standard in the field [13]. Recall
that, given a mean risk probability µ and standard deviation σ, the corresponding beta distribution has
shape parameters
α=(

(1 − µ)
1
− )µ2
σ2
µ

β = α(

1
− 1)
µ

(1)

In our simulation, we assign risk probabilities from a beta distribution with µ equal to the desired
average disease prevalence and a standard deviation of σ =

µ
2.

Next, we simulate infection of the population

by assuming that our disease risk probabilities are exactly accurate—that is, each risk probability represents
the probability of infection for the corresponding individual. Thus, each individual is assigned a disease status
(0 = uninfected, 1 = infected) according to a Bernoulli random variable with parameter p. This produces
a population with a unimodal distribution of risk probabilities and corresponding infection statuses, which
we proceed to decode using our group testing algorithms.

7

2.3

Array Grouping Algorithms

Figure 2: Schematics depicting the three array assignment schemes (Random, Concentrated Risk, and
Dispersed Risk) considered in this paper. Circles represent individuals, colored according to disease risk,
and dotted lines represent groups of individuals to be put into arrays for testing.

2.3.1

Random Array Assignment

As a baseline for comparison, we employ a random array assignment algorithm: given an array size a and
a population size n, the highest-risk n mod a individuals are set aside for individual testing, while the
remaining individuals are equally and randomly partitioned into array groups of size a (Figure 2).

2.3.2

”Concentrated Risk” Array Assignment

As mentioned above, this algorithm seeks to maximize the number of negative arrays by concentrating the
highest-risk individuals in as few array groups are possible. Given an array size a and a population size n,
the highest-risk n mod a individuals are set aside for individual testing. From the remaining individuals,
the highest-risk a are grouped into an array, the next highest-risk a are grouped into the next array, and so
on, until all array groups are filled (Figure 2).

2.3.3

”Dispersed Risk” Array Assignment

This algorithm seeks to maximize the number of few-positive arrays by systematically spreading the highestrisk individuals among available array groups. Given an array size a and a population size n, the highest-risk
n mod a individuals are set aside for individual testing. From the remaining individuals, the highest-risk
individual is placed into the first array group, the second highest-risk is placed into the next array group,
and so on, until all array groups are filled (Figure 2).
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2.4
2.4.1

Simulation Workflow
Key Simplifying Assumptions

While some of these assumptions are mentioned above, below we list all of the major simplifying assumptions
used in our simulations, with a rationale for each:

Assumption 1: For the purposes of this initial investigation, we assume perfect tests. That is, given
a positive sample, any test will return a positive result with probability 1 (i.e. test sensitivity = 1), and
given a negative sample, any test will return a negative result with probability 1 (i.e. test specificity = 1).
While no real-world diagnostic test attains 100% accuracy, imperfect tests somewhat complicate array test
interpretation, and with PCR-based COVID-19 tests approaching 80% sensitivity and 99% specificity and
recent results which indicate that testing sensitivity is secondary to other testing parameters for effective
surveillance [8], we argue that this assumption is not particularly detrimental to our goals.

Assumption 2: For the purposes of this initial investigation, we assume square testing arrays of side
length 3 to 8 (array size 9 to 64). While considering square arrays slightly simplifies analysis, our methods
can easily be adapted to rectangular arrays; however, we argue that square arrays are easier to implement in
practice and thus might be preferable to rectangular arrays. A maximum array size of 64 was chosen based on
studies reporting unaffected COVID-19 PCR test accuracy for 8-sample pools [21, 14] and to accommodate
the standard 8x12 96-well plate commonly used in testing laboratories.

Assumption 3: In conducting an array test, we adopt the standard procedure: given an array, we group
each row and each column (if the array is n by n, this produces 2n groups). Each group is then tested,
and samples at the intersection of a positive row and column group are then retested individually to decode
their disease statuses. Importantly, we include a modification to this procedure; since we assume perfect
tests, we also assume that, given only a single row and column test positive in an array, the sample at their
intersection is declared positive without a second testing round. Even under a more realistic scenario where
retesting these samples to confirm disease status is desired, this retesting can occur at the same time as
contact tracing and quarantine measures are initiated, without losing the institution any valuable response
time.

Assumption 4: As mentioned above, we assume that individual risk probabilities are exactly accurate.
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While this assumption is almost certainly unrealistic, considerations of the accuracy of risk data for informative group testing—an eminent problem in the field—are beyond the scope of the current investigation.

2.4.2

Simulation Steps

Figure 3: Schematic representing the workflow used to simulate informative array testing of a moderatelysized (n=5000) diseased population. Ten simulations were run and averaged for each combination of disease
prevalence, array assignment method, and array construction method.

2.4.3

Testing Performance Metrics

In evaluating the absolute and relative performances of our group testing algorithms, we consider two key
metrics. The first, testing efficiency (ET ) is defined as the number of tests required (t) as a proportion of
the population (n):
ET =

t
n

(2)

and is standard in the field. In addition, we define another metric, decoding efficiency (ED ) as the proportion of the population whose disease status is decoded after the first round of testing (recall that informative
array testing can require up to 2 rounds of testing, and hierarchical schemes may require more). We argue
that this metric is useful to institutions conducting frequent surveillance testing of large populations—in
some cases, a group testing strategy which saves slightly less tests but effectively decodes a majority of the
population after only a single round of testing may be more useful at facilitating rapid contact tracing and
outbreak containment.
10

3

Results

3.1

Array testing simulation recapitulates key group testing phenomena

As an initial observation, we note that, among all population and testing parameters, group testing efficiency
remains below 1 at disease prevalence below approximately 30% (Figure 4). This is to say that group testing
uses a greater number of tests than individual testing if disease prevalence is higher than approximately
30%, a threshold consistent with group testing literature [17]. In addition, larger array sizes tend to produce
greater test savings (recall that, given our definition of testing efficiency, a lower magnitude is of this metric is
preferable), although this effect is more pronounced at low disease prevalence (Figure 4). As expected, overall
testing efficiencies are best at low disease prevalence and worsen gradually as prevalence increases; yet, even
at relatively high prevalence ( 10%), informative array testing can potentially reduce testing loads by roughly
40%. Finally, examining the decoding efficiencies as a whole (Figure 5) underscores the advantage of array
testing over other group testing approaches: at disease prevalences below approximately 10%, informative
array testing can decode over 60% (and as high as 99%!) of the testing population after only a single round
of testing. Interestingly, under our simulation conditions, smaller array sizes tend to produce more desirable
decoding efficiencies despite having less desirable testing efficiencies at most prevalences (Figure 5, Table 1).
With regard to array construction, our simulation recapitulates published results [13] demonstrating that,
across testing and disease parameters, gradient array construction slightly outperforms spiral construction.
For this reason, we focus our analysis on the gradient array construction method.

3.2

Testing and decoding efficiencies appear largely agnostic to array assignment strategy

Under our simulation conditions, it appears that both testing and decoding efficiencies within a single array
size are strikingly similar among all three array assignment algorithms investigated (Figures 4 and 5). While
there are prevalence regimes where dispersed risk array assignment is marginally more efficient than random
array assignment, these differences are on the order of tens of tests in a population of 5000–too small to be
of practical importance. One potential exception to this observation is seen at high disease prevalence and
large array sizes, where the concentrated risk array assignment method begins to outperform both random
and dispersed assignment strategies at prevalences past 20%. Although also relatively small in magnitude,
this performance gain may be influenced by different simulation parameters (imperfect tests and larger
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Figure 4: Testing efficiencies (number of tests as a proportion of the population size) of three array assignment
algorithms with subsequent array construction using the gradient method. Disease prevalence ranges from
0% to 30%, and panels represent differing array sizes (i.e. 36 is equivalent to 6 by 6 testing arrays). Note
that the y-axis does not begin at 0. A testing efficiency of 1 (equivalent to individual testing) is indicated
with dotted lines.

Figure 5: Decoding efficiencies (the proportion of the population whose disease status is decoded after one
round of testing) of three array assignment algorithms with array construction using the gradient method.
Disease prevalence ranges from 0% to 30%, and panels represent differing array sizes (i.e. 36 is equivalent
to 6 by 6 testing arrays). Note that the y-axis does not begin at 0. A decoding efficiency of 1 (equivalent to
decoding the entire population after one round of testing) is indicated with dotted lines.
populations), warranting further investigation.
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Prevalence
0.05
0.1
0..2

9
0.976
0.913
0.742

16
0.954
0.861
0.632

Array
25
0.934
0.813
0.538

Size
36
0.905
0.752
0.478

49
0.886
0.721
0.408

64
0.863
0.675
0.345

Table 1: Decoding efficiencies (the proportion of the population whose disease status is decoded after a single
round of testing) for the indicated prevalence values and array sizes using dispersed risk array assignment
and gradient array construction algorithms.

4

Conclusions and Future Work

4.1

Prioritizing array construction over assignment in optimizing informative
array testing

While we were unable to find published results discussing methods of array assignment in informative array
testing schemes, our current simulations suggest that testing and decoding efficiency gains in informative
array testing are more responsive to array construction rather than assignment. While gradient or spiral
construction has been shown to outperform random array construction [13], our data suggest that any
performance improvements resulting from strategic array construction are marginal. This observation may
be explained in the context of our population risk landscape –in cases where individual disease risks are
tightly clustered around a relatively low-risk mean, dispersing high-risk individuals and randomly dispersing
all individuals may produce similar testing array groups, resulting in similar testing and decoding efficiencies.
The finding that concentrated risk array assignment slightly outperforms random and dispersed algorithms at high prevalence mimics a finding previously documented in hierarchical testing – specifically, the
Threshold Optimal Dorfman (TOD) group testing algorithm was reported to perform well at high prevalences [12]. Interestingly, both TOD and concentrated risk array assignment serve to amalgamate high-risk
individuals. The better performance of these algorithms at high disease prevalence may therefore suggest a
more generalized group testing operating characteristic.
The possibility that informative array testing efficiency is insensitive to array assignment strategy is of
potential importance to institutions seeking to conduct informative array testing for disease surveillance. As
mentioned previously, effective disease surveillance is a careful balance between optimizing for testing efficiency without sacrificing implementation complexity. Notably, the ability to assign array groups randomly
alleviates institutions’ need to collect an entire population of samples before forming array groups–instead,
laboratories may assign array groups as samples arrive in the laboratory, focusing only on constructing the
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arrays themselves, and thus reducing the possibility for human error.

4.2

The importance of balancing testing and decoding efficiency when considering informative array testing strategies

Our simulations also suggest an interesting balance between testing and decoding efficiencies with regards
to informative array testing. Specifically, we find that smaller array sizes–while generally saving fewer tests
than larger arrays–tend to decode higher proportions of the population after one round of testing, especially
in prevalence regimes between 10% and 20%. In addition, population decoding by smaller arrays tends to
be more robust to increasing disease prevalence than that of larger arrays. Decoding efficiency is potentially
important for institutions requiring large-scale and nimble disease monitoring strategies; the faster cases
can be identified, the quicker contact tracing protocols may be initiated to stem outbreaks [8]. Thus, our
simulations reject the notion that, when it comes to informative array testing, bigger arrays are always better
than smaller arrays. Institutions interested in optimizing informative array testing must carefully weigh the
costs and benefits of increased tests savings and decreased decoding efficiency, and middle-of-the-road array
sizes may present the optimal balance between these two considerations.

4.3

Future Work

Of course, the simulations presented here represent an initial foray into optimizing array assignment for
informative array disease testing, and further theoretical and experimental studies are needed before definitive
conclusions or recommendations can be drawn. Further development of the work described here should
focus on systematically relaxing the assumptions of perfect tests and risk probabilities, and more extensive
simulations of larger populations will assist in generalizing the observations noted in this report. Continued
study of group testing–and informative group testing in particular–is a worthwhile venture as our capabilities
to simultaneously detect disease and estimate individual disease risks continue to improve.
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5
5.1

Appendix
Supplemental Figures

Figure 6: Testing efficiencies (number of tests as a proportion of the population size) of three array assignment
algorithms with subsequent array construction using the gradient and spiral methods. Disease prevalence
ranges from 0% to 30%, and panels represent differing array sizes (i.e. 36 is equivalent to 6 by 6 testing
arrays). Note that the y-axis does not begin at 0. A testing efficiency of 1 (equivalent to individual testing)
is indicated with dotted lines.

5.2

R Code

R code which conducts the testing simulations described in this document and produces the source data for
all figures is available at https://github.com/davemanthecaveman/Informative-Array-Testing-Thesis.git.
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